10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0000950170-25-065675`
Period End Date	20250331
Filing Date	20250507
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	slno-20250331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 62 Cash Flow Statement 112 Stockholders Equity 40

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.93M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	45.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	45.70M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.33M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.53M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.53M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$203.51M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$203.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	45.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	45.70M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$208.62M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$208.62M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$18.96M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$18.96M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$308.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$308.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$293.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$293.89M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$186.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$186.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$173.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$173.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.60M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.60M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.80M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.32M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.32M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$27.21M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$27.21M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	-	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	-	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Total assets	`Assets`	$318.09M	USD	Point-in-time
Total assets	`Assets`	$318.09M	USD	Point-in-time
Total assets	`Assets`	$330.97M	USD	Point-in-time
Total assets	`Assets`	$330.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.88M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.78M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.78M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.28M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.28M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.83M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.83M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.82M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.82M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$597.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$597.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$526.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$526.00K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$423.00K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$423.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.74M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.74M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.73M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.73M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$14.79M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$14.79M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$17.76M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$17.76M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.83M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.83M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.84M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$49.84M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.36M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.36M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.47M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.47M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$21.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$21.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$145.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$145.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$85.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$85.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$85.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$85.83M	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 48,527,469 and 45,703,811 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 48,527,469 and 45,703,811 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 48,527,469 and 45,703,811 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 48,527,469 and 45,703,811 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$696.97M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$696.97M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$728.02M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$728.02M	USD	Point-in-time
Accumulated other comprehensive gain	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$361.00K	USD	Point-in-time
Accumulated other comprehensive gain	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$361.00K	USD	Point-in-time
Accumulated other comprehensive gain	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$226.00K	USD	Point-in-time
Accumulated other comprehensive gain	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$226.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-496.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-496.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-452.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-452.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$245.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$245.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$232.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$232.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$318.09M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$318.09M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$330.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$330.97M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$13.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$13.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.60M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$29.26M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$29.26M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.47M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.47M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.97M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.97M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.48M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.48M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$45.74M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$45.74M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.48M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.48M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-45.74M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-45.74M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.08M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.08M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.33M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.33M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.36M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.36M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$2.08M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$2.08M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.97M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-139.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-139.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-105.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-105.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.91M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.91M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.50M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.50M	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.59	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.59	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.95	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.95	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.59	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.59	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.95	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.95	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	46.18M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	46.18M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46.18M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46.18M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.21M	shares	1 Quarter

Cash Flow Statement 112 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-21.40M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.40M	USD	1 Quarter
Net loss	`ProfitLoss`	$-43.77M	USD	1 Quarter
Net loss	`ProfitLoss`	$-43.77M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$504.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$504.00K	USD	1 Quarter
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$980.00K	USD	1 Quarter
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$980.00K	USD	1 Quarter
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$473.00K	USD	1 Quarter
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$473.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$195.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$195.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$69.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$69.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$8.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$8.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.45M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.45M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$14.68M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$14.68M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.97M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.97M	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$4.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$4.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-1.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-1.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-81.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-81.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.42M	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.42M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.34M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.34M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.87M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.87M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.91M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.91M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-499.00K	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-499.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-2.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-2.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-998.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-998.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-40.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-40.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-56.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-56.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$937.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$937.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-44.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-44.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.75M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.75M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.53M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.00K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$45.36M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$45.36M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$115.23M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$115.23M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$68.30M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$68.30M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.94M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.94M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-115.24M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-115.24M	USD	1 Quarter
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$62.00K	USD	1 Quarter
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$62.00K	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$923.00K	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$923.00K	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$3.01M	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$3.01M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$269.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$269.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$15.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$15.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.22M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.22M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$938.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$938.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.60M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.60M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-126.83M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-126.83M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.33M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.33M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.33M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.33M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$805.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$805.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.00K	USD	1 Quarter

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$232.26M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$232.26M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.68M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.68M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$15.00K	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$15.00K	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$13.37M	USD	1 Quarter
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting`	$13.37M	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$3.01M	USD	1 Quarter
Exercise of common stock warrants	`ExerciseOfCommonStockWarrants`	$3.01M	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-139.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-139.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$245.11M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$232.26M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$232.26M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.